Investigator Initiated

ASPIRING logo
ASPIRING

Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe Lead PI: Professor Graeme J. Hankey and Professor Craig S. Anderson  Participating Australian and New…

avert dose logo revised
AVERT DOSE

A trial to Determine the Optimal early mobility Training after Stroke AVERT DOSE: A trial to Determine the Optimal early…

Screen Shot 2022-05-18 at 3.14.34 pm
CASPER

CASPER: Colchicine After Stroke to Prevent Event Recurrence Chief Investigator A: Prof. Anthony Keech, NHMRC Clinical Trial Centre Chief Investigator…

DIRECT-SAFE
DIRECT-SAFE

A randomised controlled trial of DIRECT endovascular clot retrieval versus standard bridging thrombolysis with endovascular clot retrieval within 4.5 hours…

ESCAPE-Next
ESCAPE-Next

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with…

EVACUATE
EVACUATE-RCT

Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment Lead PI: Prof Timothy Kleinig Status: ASTN endorsed, Site selection, Recruiting…

INTERACT3
INTERACT3

INTEnsive care bundle with blood pressure Reduction in Acute Cerebral haemorrhage Trial Lead PI:  Prof. Craig Anderson Status: Recruiting No. of…

OPTIMISTmain
OPTIMISTmain

Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Lead PI: Professor Craig Anderson Status: Recruiting, Site selection No. of Patients Currently Recruited: 18 …

PESTO

 A Prospective multicentre, phase 2b randomised controlled double-blind trial, to determine the safety and efficacy of perispinal etanercept on quality…

1 2